Clinical Trial Update: Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in metastatic PD-L1 positive triple-negative breast cancer evaluating induction therapy with paclitaxel plus bevacizumab followed by at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Nab-paclitaxel (paclitaxel protein-bound)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Japan Breast Cancer Research Group | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING